ValuationViz

KRYS fund manager activity

Krystal Biotech, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q1 2023 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementNew3,786$933,3990.00%Feb 9, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed1,303$321,2420.00%Feb 17, 2026
Torray FundsAdded11,985$2,954,7820.42%Jan 28, 2026

Q3 2025

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementNew1,307$230,7250.00%Nov 14, 2025
Torray FundsAdded11,901$2,100,8840.29%Oct 22, 2025

Newer quarters · Older quarters